Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Normal Glucose Greater than 85mg/dL in Kids Predicts Diabetes Later Posted: Sunday, February 14, 2010

Increases in fasting plasma glucose during childhood -- even though levels remain in the normal range 85-100mg/dL.) -- can predict adult prediabetes and Type 2 diabetes later in life, a retrospective cohort study showed.

Preventing Diabetes for Ten Years Plus Posted: Sunday, February 14, 2010

Ten-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

Severe Complications of Diabetes Higher in Patients with Major Depression Posted: Sunday, February 14, 2010

Major depression raises risks of advanced and severe complications from diabetes, according to a prospective study. These complications include kidney failure or blindness, the result of small vessel damage, as well as major vessel problems leading to myocardial infarction (MI) or stroke.

Artificial Pancreas Improves Glucose Control Posted: Sunday, February 14, 2010

Closed-loop insulin delivery systems can improve overnight blood sugar control and reduce hypoglycemia risk in young patients with Type 1 diabetes, researchers have found.

US Health-Risk Surveillance Results Posted: Sunday, February 14, 2010

Results from January 2007 to December 2007 from the Behavioral Risk Surveillance System (BRFSS), an ongoing telephone survey of US adults on health-risk behaviors and the use of preventative healthcare services related to the leading causes of death and disability in the United States, were reported last week.

Overeating Destroys Normal Metabolism and Sets Stage for Diabetes Posted: Sunday, February 14, 2010

Overeating triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes.

Caloric Restriction with or without Exercise: The Fitness versus Fatness Debate Posted: Sunday, February 14, 2010

There is a debate over the independent effects of aerobic fitness and body fatness on mortality and disease risks.

Aspirin Associated with Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes Posted: Sunday, February 07, 2010

Regular low-dose aspirin may reduce all-cause and CVD mortality in a primary prevention setting in Type 2 diabetes.

MRI Reveals Risk for Kidney Failure in Diabetic Patients Posted: Sunday, February 07, 2010

So-called silent strokes, visible on cerebral MRI scans, predict kidney failure in patients with Type 2 diabetes, researchers said.

New GLP-1 Medication Lowers A1c Six Months after Treatment Stopped Posted: Sunday, February 07, 2010

Transition Therapeutics announces results of a Phase 2 study of TT-223 (GLP-1 Cpd + Gastrin) in Type 2 diabetes patients. The results show that beta-cells can possibly be generated and/or restored. After a 10 week trial the drug was stopped and 6 months later, the A1c had dropped by 1.13 points.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.